Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Roche Holding Ltd.    ROG

Delayed Quote. Delayed BATS Europe - 07/29 11:20:30 am
279.85 CHF   +1.14%
07/23DJBristol-Myers Revenue Boosted by Cancer Drug Opdivo
07/23DJBristol-Myers Gets a Revenue Boost from Opdivo
07/23DJRoche Battered by Strong Swiss Franc -- Update
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Swiss Exchange
07/23/2015 07/24/2015 07/27/2015 07/28/2015 07/29/2015 Date
279.5(c) 277.3(c) 273.9(c) 276.7(c) 279.6(c) Last
1 496 298 1 016 931 1 174 171 1 218 482 1 367 047 Volume
+1.56% -0.79% -1.23% +1.02% +1.05% Change
More quotes
Financials ( CHF)
Sales 2015 48 027 M
EBIT 2015 17 048 M
Net income 2015 10 774 M
Debt 2015 11 046 M
Yield 2015 3,00%
Sales 2016 50 215 M
EBIT 2016 18 313 M
Net income 2016 12 081 M
Debt 2016 6 835 M
Yield 2016 3,20%
PER 2015 21,58
PER 2016 19,28
EV / Sales 2015 5,19x
EV / Sales 2016 4,88x
Capitalization 238 239 M
More Financials
Company
Roche Holding AG operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics.It operates business through two divisons: Pharmaceuticals and Diagnostics.The Pharmaceuticals divison comprises the two business segments Roche Pharmaceuticals and Chugai,... 
Sector
Pharmaceuticals
Calendar
07/28 | 06:00pmPresentation
More about the company
Surperformance© ratings of Roche Holding Ltd.
Trading Rating : Investor Rating :
More Ratings
Latest news on ROCHE HOLDING LTD.
07/23DJBristol-Myers Revenue Boosted by Cancer Drug Opdivo
07/23DJBristol-Myers Gets a Revenue Boost from Opdivo
07/23DJRoche Battered by Strong Swiss Franc -- Update
07/23DJRoche Battered by Strong Swiss Franc
07/23DJRoche Battered by Strong Swiss Franc
07/22DJLilly's Alzheimer's Drug May Slow Patients' Decline, Study Shows -- Update
07/20DJRoche Holding AG HY 2015 -- Forecast
07/16 Immunocore raises $320 million in record financing round
More news
Sector news : Pharmaceuticals - NEC
09:51a 2ND UPDATE : GlaxoSmithKline On Track For 2015 And Confident For 2016
09:46a AKORN : The Law Firm of Morgan & Morgan Is Investigating Possible Breaches of Fi..
09:33aDJHospira Earnings Beat on Strength in Specialty Injectables -- Update
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
07/28 Boehringer Ingelheim teams up with Hanmi Pharma on 3rd gen EGFR candidate
07/28 Teva's MAA for reslizumab validated; decision expected in second half of 2016
07/28 THRESHOLD PHARMACEUTICALS : Hard Road Toward Success
07/27 HIV/HPV Guru Comes On Board To Battle Cancer, Driving CEL-SCI's Market Opport..
07/27 BIOGEN FALLS HARD : Is It Undervalued Now?


Comments 
Advertisement
Chart ROCHE HOLDING LTD.
Duration : Period :
Roche Holding Ltd. Technical Analysis Chart | ROG | CH0012032048 | 4-Traders
Full-screen chart
Technical analysis trends ROCHE HOLDING LTD.
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions